T1	CHEM 103 115	vortioxetina
#1	AnnotatorNotes T1	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T2	DISO 130 139	depresión
#2	AnnotatorNotes T2	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T3	PROC 247 254	placebo
#3	AnnotatorNotes T3	C0032042; Placebos; Therapeutic or Preventive Procedure
T4	PROC 292 298	ciegos
T5	PROC 322 429	Estudio intervencional, aleatorizado, con doble enmascaramiento, controlado con placebo, con control activo
T6	PROC 1262 1286	consentimiento informado
#4	AnnotatorNotes T6	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T7	CHEM 431 441	fluoxetina
#5	AnnotatorNotes T7	C0016365; fluoxetine; Organic Chemical · Pharmacologic Substance
T8	CHEM 459 471	vortioxetina
#6	AnnotatorNotes T8	C3661282; vortioxetine; Organic Chemical · Pharmacologic Substance
T9	DISO 516 541	trastorno depresivo mayor
#7	AnnotatorNotes T9	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T10	DISO 543 546	TDM
#8	AnnotatorNotes T10	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T11	DISO 571 580	Depresión
#9	AnnotatorNotes T11	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction
T12	DISO 607 633	Transtorno depresivo mayor
#10	AnnotatorNotes T12	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T13	DISO 865 890	trastorno depresivo mayor
#11	AnnotatorNotes T13	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T14	DISO 892 895	TDM
#12	AnnotatorNotes T14	C1269683; Major Depressive Disorder; Mental or Behavioral Dysfunction
T15	PROC 897 910	diagnosticado
#13	AnnotatorNotes T15	C0011900; Diagnosis; Diagnostic Procedure
T16	PROC 1347 1362	estudio clínico
#14	AnnotatorNotes T16	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T17	Date 13 17	2008
T18	LIVB 259 271	investigador
#15	AnnotatorNotes T18	C0035173; Research Personnel; Professional or Occupational Group
T19	LIVB 278 285	sujetos
#16	AnnotatorNotes T19	C0681850; Study Subject; Group
T20	LIVB 475 496	pacientes pediátricos
#17	AnnotatorNotes T20	C0030705; Patients; Patient or Disabled Group + C0008059; Child; Age Group
T21	Age 497 511	de 7 a 11 años
T22	LIVB 663 701	paciente, de sexo femenino o masculino
#18	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group + C0043210; Woman; Population Group + C0025266; Male population group; Population Group
T23	LIVB 764 773	pacientes
#19	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	Age 786 793	12 años
T25	LIVB 852 860	paciente
#20	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	LIVB 933 941	paciente
#21	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 1040 1048	paciente
#22	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 1136 1144	paciente
#23	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	LIVB 1317 1325	paciente
#24	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group
T30	Duration 1363 1371	<30 días
T31	LIVB 144 156	adolescentes
#25	AnnotatorNotes T31	C0205653; Adolescent (age group); Age Group
T32	Age 706 724	entre ≥7 y <12años
T33	LIVB 1191 1205	progenitor(es)
#26	AnnotatorNotes T33	C0030551; parent; Family Group
T34	LIVB 1207 1233	representante(s) legal(es)
T35	Dose 445 455	dosis fija
#27	AnnotatorNotes T35	C5548493; Fixed dose; Quantitative Concept
T36	PROC 973 979	CDRS-R
#28	AnnotatorNotes T36	C4274289; Assessment using RCADS (Revised Children's Anxiety and Depression Scale); Diagnostic Procedure (?)
T37	PROC 1071 1076	CGI-S
#29	AnnotatorNotes T37	C5396527; Assessment using Children's Global Assessment Scale; Health Care Activity (?)
T38	PROC 1384 1403	visita de selección
#30	AnnotatorNotes T38	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T39	PROC 1089 1108	visita de selección
#31	AnnotatorNotes T39	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T40	PROC 993 1012	visita de selección
#32	AnnotatorNotes T40	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T41	PROC 1117 1123	visita
#33	AnnotatorNotes T41	C1512346; Patient Visit; Health Care Activity
T42	PROC 1021 1027	visita
#34	AnnotatorNotes T42	C1512346; Patient Visit; Health Care Activity
T43	PROC 739 758	visita de selección
#35	AnnotatorNotes T43	C1710477; Trial Screening; Research Activity + C1512346; Patient Visit; Health Care Activity
T44	Quantifier_or_Qualifier 1028 1033	basal
#36	AnnotatorNotes T44	C1442488; Baseline; Quantitative Concept
T45	Quantifier_or_Qualifier 1124 1129	basal
#37	AnnotatorNotes T45	C1442488; Baseline; Quantitative Concept
A1	Population_data T31 Age
A2	Population_data T20 Age
A3	Status T16 History_of
R1	Experiences Arg1:T31 Arg2:T2	
R2	Experiences Arg1:T31 Arg2:T1	
T46	CONC 216 226	comparador
#38	AnnotatorNotes T46	C4553390; Comparator; Intellectual Product
#39	AnnotatorNotes T4	C0013072; Double-Blind Method; Research Activity | C0150108; Blinded; Research Activity
T47	CONC 415 429	control activo
#40	AnnotatorNotes T47	C2347177; Active Comparator; Conceptual Entity
R3	Has_Dose_or_Strength Arg1:T8 Arg2:T35	
R4	Experiences Arg1:T20 Arg2:T8	
R5	Experiences Arg1:T20 Arg2:T7	
R6	Has_Age Arg1:T20 Arg2:T21	
R7	Experiences Arg1:T20 Arg2:T9	
R8	Experiences Arg1:T20 Arg2:T10	
R9	Has_Age Arg1:T22 Arg2:T32	
R10	Overlap Arg1:T43 Arg2:T32	
R11	Has_Age Arg1:T23 Arg2:T24	
R12	Overlap Arg1:T43 Arg2:T24	
R13	Experiences Arg1:T25 Arg2:T13	
R14	Experiences Arg1:T25 Arg2:T14	
T48	CONC 920 925	DSM-5
#41	AnnotatorNotes T48	C4236906; Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); Intellectual Product
R16	Used_for Arg1:T48 Arg2:T15	
R17	Experiences Arg1:T26 Arg2:T36	
T49	Result_or_Value 983 986	≥45
R18	Has_Result_or_Value Arg1:T36 Arg2:T49	
R19	Overlap Arg1:T36 Arg2:T40	
R20	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T44	
R21	Overlap Arg1:T36 Arg2:T42	
R22	Experiences Arg1:T27 Arg2:T37	
T50	Result_or_Value 1080 1082	≥4
R23	Has_Result_or_Value Arg1:T37 Arg2:T50	
R24	Overlap Arg1:T37 Arg2:T39	
R25	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T45	
R26	Overlap Arg1:T37 Arg2:T41	
T51	Observation 1148 1188	otorgado su asentimiento para participar
#42	AnnotatorNotes T51	C1302239; Patient consented to clinical trial; Finding
R28	Has_Duration_or_Interval Arg1:T16 Arg2:T30	
R29	Before Arg1:T16 Arg2:T38	
#43	AnnotatorNotes T34	C4288823; Legal Representative for the Study; Human
#44	AnnotatorNotes T5	C3274035; Interventional Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity + C1706449; Active Control; Research Activity
T52	Observation 73 79	efecto
#45	AnnotatorNotes T52	C1518681; Outcome of Therapy; Finding (?)
R15	Causes Arg1:T1 Arg2:T52	
R30	Experiences Arg1:T31 Arg2:T52	
T53	Observation 164 171	efectos
#46	AnnotatorNotes T53	C1518681; Outcome of Therapy; Finding (?)
R31	Causes Arg1:T46 Arg2:T53	
R32	Causes Arg1:T3 Arg2:T53	
R33	Experiences Arg1:T22 Arg2:T43	
R34	Experiences Arg1:T23 Arg2:T43	
R35	Experiences Arg1:T27 Arg2:T39	
R36	Experiences Arg1:T29 Arg2:T38	
R37	Experiences Arg1:T26 Arg2:T40	
R38	Experiences Arg1:T26 Arg2:T42	
R39	Experiences Arg1:T27 Arg2:T41	
A4	Experiencer T31 Patient
A5	Experiencer T18 Other
A6	Experiencer T19 Patient
A7	Experiencer T20 Patient
A8	Experiencer T22 Patient
A9	Experiencer T23 Patient
A10	Experiencer T25 Patient
A11	Experiencer T26 Patient
A12	Experiencer T27 Patient
A13	Experiencer T28 Patient
A14	Experiencer T33 Family_member
A15	Experiencer T34 Other
A16	Experiencer T29 Patient
